Cover Image
Market Research Report

CRISPR Technology: Global Markets

Published by BCC Research Product code 936417
Published Content info 83 Pages
Delivery time: 1-2 business days
Price
Back to Top
CRISPR Technology: Global Markets
Published: May 8, 2020 Content info: 83 Pages
Description

Highlights:

The global market for CRISPR technology should grow from $75.0 billion in 2018 to $218.9 billion by 2023, at a compound annual growth rate (CAGR) of 23.9% for the period of 2018-2023.

Biotechnology companies market should grow from $24.9 billion in 2018 to $73.3 billion by 2023 at a CAGR of 24.1% through 2023.

Pharmaceutical companies market should grow from $17.0 billion in 2018 to $52.8 billion by 2023 at a CAGR of 25.4% through 2023.

Report Scope:

The scope of this report is broad, covering the applications of CRISPR in medicine, drug therapy and agriculture. The market for CRISPR technology is broken down by application and end user. Revenue forecasts from 2018-2023 are given for each end user category and application with estimated value derived from the revenue of the companies' total revenues.

This report also includes a discussion of the major players across each regional market for CRISPR technology with respect to prominent strategic initiatives. Further, it explains the main drivers and regional dynamics of the global market and current trends within the industry.

Report Includes:

  • 45 data tables and 35 additional tables
  • An overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline in animal, human and other organisms
  • Analyses of global market trends, with market data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Explanation of the major drivers and regional dynamics of the global CRISPR market and evaluation of its current market size, and market forecast
  • Comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
  • Information on congenital anomalies, its prevalence, causes and its relation to mortality rate
  • Knowledge about Cell Line Engineering, CRISPR Plasmid, Genetic Engineering, GRNA Database/Gene Library and Human Stem Cells
  • Insights into regulatory framework and investment analysis
  • Market share analysis of the leading suppliers of the industry and their detailed company profiles, including Caribou Biosciences, Genscript, Integrated DNA Technologies, Intellia Therapeutics Inc., Precision Biosciences, Sangamo Therapeutics Inc., and Thermo Fisher Scientific
Table of Contents
Product Code: HLC258A

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

  • CRISPR: Genetic Editing
  • Pros of Genetic Editing
  • CRISPR Development Phases
  • Discovery of CRISPR
  • Discovery of Cas9 and PAM
  • Hypothesis: Adaptive Immunity
  • Adaptive Immunity
  • Spacer Sequences: gRNAs
  • CRISPR Acts on DNA Targets
  • Cas9 Cleaves Target DNA
  • tracrRNA for Cas9 Systems
  • CRISPR Systems in Other Species
  • Cas9-Mediated Cleavage
  • CRISPR-Cas9: Genome Editing
  • Market Potential
  • Regulatory Framework
  • U.S. Regulation and Oversight
  • NIH Guidelines
  • U.S. FDA
  • Ethical Considerations
  • Regulatory Issues
  • Regulations of Human Germline Edits
  • Global Regulations
  • Porter's Five Forces Analysis
  • Patent Analysis
  • Overview of CRISPR Technology Intellectual Property (IP) and Licensing Structure
  • Industry Drivers
  • CRISPR versus Disease
  • Government Funding
  • CRISPR in Other Fields
  • Industry Restraints
  • Alternative Technologies
  • Industry Challenges
  • Patent Issues

Chapter 4 Industry Structure

  • Commercial Therapeutics
  • Correcting Genetic Errors
  • Microbes
  • Healthier Food

Chapter 5 Competitive Landscape

  • Cellectis
  • CRISPR Therapeutics
  • Editas Medicine
  • Intellia Therapeutics
  • Sangamo Therapeutics

Chapter 6 Global Market for CRISPR Technology by End User

  • Academic Institutes
  • Research and Development Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies

Chapter 7 Global Market for CRISPR Technology by Application

  • Cell Line Engineering
  • CRISPR Plasmid
  • Genetic Engineering
  • GRNA Databases/Gene Libraries
  • Human Stem Cells

Chapter 8 Global Market for CRISPR Technology by Region

  • North America
  • U.S.
  • Europe
  • UK
  • Asia-Pacific
  • China
  • India
  • Rest of the World

Chapter 9 Company Profiles

  • CARIBOU BIOSCIENCES
  • CRISPR THERAPEUTICS
  • EDITAS MEDICINE
  • GENSCRIPT
  • HORIZON DISCOVERY PLC
  • INTEGRATED DNA TECHNOLOGIES
  • INTELLIA THERAPEUTICS INC.
  • LONZA GROUP LTD.
  • NEW ENGLAND BIOLABS INC.
  • ORIGENE TECHNOLOGIES
  • PRECISION BIOSCIENCES
  • SANGAMO THERAPEUTICS INC.
  • THERMO FISHER SCIENTIFIC
  • TRANSPOSAGENBIO BIOPHRAMACEUTICALS (HERA BIOLABS)

List of Tables

  • Summary Table : Global Market for CRISPR Technology, by End User, Through 2023
  • Table 1 : Selected Monogenic Disease Details
  • Table 2 : CRISPR Application
  • Table 3 : Selected CAR-T/Gene-Editing Collaborations
  • Table 4 : CRISPR Technology: Selected Companies
  • Table 5 : CRISPR Technology: Selected Mergers and Acquisitions
  • Table 6 : CRISPR Technology: Selected Joint Ventures
  • Table 7 : CRISPR Technology: Recent Developments
  • Table 8 : CRISPR Technology: Competitive Scenario
  • Table 9 : Global Market for CRISPR Technology Used by Academic Institutes, Through 2023
  • Table 10 : Global Market for CRISPR Technology Used by Academic Institutes, by Region, Through 2023
  • Table 11 : Global Market for CRISPR Technology Used by R&D Institutes, Through 2023
  • Table 12 : Global Market for CRISPR Technology Used by R&D Institutes, by Region, Through 2023
  • Table 13 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, Through 2023
  • Table 14 : Global Market for CRISPR Technology Used by Pharmaceutical Companies, by Region, Through 2023
  • Table 15 : Global Market for CRISPR Technology Used by Biotechnology Companies, Through 2023
  • Table 16 : Global Market for CRISPR Technology Used by Biotechnology Companies, by Region, Through 2023
  • Table 17 : Global Market for CRISPR Technology, by Application, Through 2023
  • Table 18 : Global Market for CRISPR Technology in Cell Line Engineering Applications, Through 2023
  • Table 19 : Global Market for CRISPR Technology in Cell Line Engineering Applications, by Region, Through 2023
  • Table 20 : Global Market for CRISPR Technology in Plasmid Applications, Through 2023
  • Table 21 : Global Market for CRISPR Technology in Plasmid Applications, by Region, Through 2023
  • Table 22 : Global Market for CRISPR Technology in Genetic Engineering Applications, Through 2023
  • Table 23 : Global Market for CRISPR Technology in Genetic Engineering Applications, by Region, Through 2023
  • Table 24 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, Through 2023
  • Table 25 : Global Market for CRISPR Technology in GRNA Database/Gene Library Applications, by Region, Through 2023
  • Table 26 : Global Market for CRISPR Technology in Human Stem Cell Applications, Through 2023
  • Table 27 : Global Market for CRISPR Technology in Human Stem Cell Applications, by Region, Through 2023
  • Table 28 : Global Market for CRISPR Technology, by Region, Through 2023
  • Table 29 : North American Market for CRISPR Technology, Through 2023
  • Table 30 : North American Market for CRISPR Technology, by End User, Through 2023
  • Table 31 : North American Market for CRISPR Technology, by Application, Through 2023
  • Table 32 : U.S. Market for CRISPR Technology, Through 2023
  • Table 33 : U.S. Market for CRISPR Technology, by End User, Through 2023
  • Table 34 : U.S. Market for CRISPR Technology, by Application, Through 2023
  • Table 35 : European Market for CRISPR Technology, Through 2023
  • Table 36 : European Market for CRISPR Technology, by End User, Through 2023
  • Table 37 : European Market for CRISPR Technology, by Application, Through 2023
  • Table 38 : UK Market for CRISPR Technology, Through 2023
  • Table 39 : UK Market for CRISPR Technology, by End User, Through 2023
  • Table 40 : UK Market for CRISPR Technology, by Application, Through 2023
  • Table 41 : Asia-Pacific Market for CRISPR Technology, Through 2023
  • Table 42 : Asia-Pacific Market for CRISPR Technology, by End User, Through 2023
  • Table 43 : Asia-Pacific Market for CRISPR Technology, by Application, Through 2023
  • Table 44 : Chinese Market for CRISPR Technology, Through 2023
  • Table 45 : Chinese Market for CRISPR Technology, by End User, Through 2023
  • Table 46 : Chinese Market for CRISPR Technology, by Application, Through 2023
  • Table 47 : Indian Market for CRISPR Technology, Through 2023
  • Table 48 : Indian Market for CRISPR Technology, by End User, Through 2023
  • Table 49 : Indian Market for CRISPR Technology, by Application, Through 2023
  • Table 50 : Rest of the World Market for CRISPR Technology, Through 2023
  • Table 51 : Rest of the World Market for CRISPR Technology, by End User, Through 2023
  • Table 52 : Rest of the World Market for CRISPR Technology, by Application, Through 2023
  • Table 53 : Caribou Biosciences: Product Portfolio
  • Table 54 : Caribou Biosciences: Recent Developments
  • Table 55 : CRISPR Therapeutics: Product Portfolio
  • Table 56 : CRISPR Therapeutics: Recent Developments
  • Table 57 : Editas Medicine: Product Portfolio
  • Table 58 : Editas Medicine: Recent Developments
  • Table 59 : Genscript: Product Portfolio
  • Table 60 : Genscript: Recent Developments
  • Table 61 : Horizon Discovery: Product Portfolio
  • Table 62 : Horizon Discovery: Recent Developments
  • Table 63 : Integrated DNA Technologies (IDT): Product Portfolio
  • Table 64 : Integrated DNA Technologies (IDT): Recent Developments
  • Table 65 : Intellia Therapeutics Inc.: Product Portfolio
  • Table 66 : Intellia Therapeutics Inc.: Recent Developments
  • Table 67 : Lonza Group Ltd.: Product Portfolio
  • Table 68 : Lonza Group Ltd.: Recent Developments
  • Table 69 : New England Biolabs Inc.: Product Portfolio
  • Table 70 : New England Biolabs Inc.: Recent Developments
  • Table 71 : OriGene Technologies: Product Portfolio
  • Table 72 : Precision BioSciences: Product Portfolio
  • Table 73 : Precision BioSciences: Recent Developments
  • Table 74 : Sangamo Therapeutics Inc.: Product Portfolio
  • Table 75 : Sangamo Therapeutics Inc.: Recent Developments
  • Table 76 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 77 : Thermo Fisher Scientific Inc.: Recent Developments
  • Table 78 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Product Portfolio
  • Table 79 : Transposagenbio Biopharmaceuticals (Hera Biolabs): Recent Developments

List of Figures

  • Summary Figure : Global Market for CRISPR Technology, by End User, 2017-2023
  • Figure 1 : Porter's Five Forces Model
  • Figure 2 : Patent Activity on CRISPR Technology, 2008-2018
  • Figure 3 : CRISPR Licensing Landscape
  • Figure 4 : NIH Funding for CRISPR Research, 2014-2018
  • Figure 5 : Global Market for CRISPR Technology, by End User, 2017-2023
  • Figure 6 : Global Market for CRISPR Technology, by Application, 2017-2023
  • Figure 7 : Global Market for CRISPR Technology, by Region, 2017-2023
Back to Top